acetaldehyde has been researched along with chiniofon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berti, F; Bongrani, S; Civelli, M; Manfredi, B; Razzetti, R; Rossoni, G | 1 |
| Esterbauer, H; Exner, M; Gmeiner, BM; Hermann, M; Jirovetz, L; Kapiotis, S; Laggner, H | 1 |
2 other study(ies) available for acetaldehyde and chiniofon
| Article | Year |
|---|---|
Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs.
Topics: Acetaldehyde; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Amphetamines; Animals; Bronchoconstriction; Bronchodilator Agents; Budesonide; Capillary Permeability; Dose-Response Relationship, Drug; Drug Synergism; Ethanolamines; Ethylamines; Formoterol Fumarate; Guinea Pigs; Histamine; Hydroxyquinolines; Inosine Triphosphate; Male; Quinolones; Substance P | 2005 |
Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.
Topics: Acetaldehyde; Cells, Cultured; Copper; Endothelial Cells; Humans; Hydroxyquinolines; Hypochlorous Acid; Lipid Metabolism; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Quinolones; Tryptophan | 2006 |